相关实验视频

Updated: Mar 7, 2026

Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol

Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol

Published on: September 21, 2021

评估布鲁克斯症和托芬代谢物之间的关系:一个案例对照研究

Gökhan Gürses¹, Ali Ünlü²

¹Selçuk University, Dentistry Faculty, Oral and Maxillofacial Surgery Department, Konya, Turkey.

Journal of oral rehabilitation

|March 6, 2026

概括

这项研究探讨了托代谢物和 Bruxism 之间的联系,在 Bruxism 患者中发现了 kynurenine 和 quinolinic 酸的水平变化. 这些发现表明这些代谢物在布鲁克斯病理生理学中的潜在作用.

科学领域:

生物化学生化学
神经科学是一个神经科学.
口腔医学是指口腔医学.

背景情况:

Bruxism 正因其临床意义和复杂的病理生理学而引起人们的注意.
了解布鲁克斯症的潜在机制对于有效的患者管理至关重要.
这项研究调查了与 Bruxism 的潜在代谢联系.

研究的目的:

调查托代谢产物与布鲁克斯症之间的潜在关系.
探索特异性托代谢物在布鲁克斯症病理生理学的作用.

主要方法:

根据确定的诊断标准,患者被分为布鲁克斯症和非布鲁克斯症组.
记录了临床数据,包括间开口,焦虑水平,感知压力和疼痛.
实验室分析测量了托及其主要代谢物,包括金氨酸和氨酸.

主要成果:

两组人群之间没有发现人口统计学差异.
在感知到的压力,间开口,焦虑和触摸时的疼痛方面发现了显著的差异.
与非布鲁克斯症组相比,布鲁克斯症患者表现出较低的金氨酸水平和较高的氨酸水平.

结论:

甲酸代谢物,特别是氨酸和氨酸,可能在布鲁克斯症的病理生理学中发挥作用.
这些代谢物的变化提供了潜在的洞察力,可以了解布鲁克斯症背后的代谢机制.
需要进一步的研究来证实这些关联并阐明它们的临床影响.

关键词:

布鲁克斯主义是什么意思这种药物是kynurenine.奇诺林酸是一种氨酸.托芬三聚氨酸是什么

更多相关视频

A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats

A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats

Published on: August 19, 2018

Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures

Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures

Published on: May 9, 2020

相关概念视频

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...